Will Building ‘Good Fences’ Really Make ‘Good Neighbors’ in Science?
The case for alternative policy approaches to intellectual property rights is argued in this paper, and several specific proposals are set out for further discussion.
The case for alternative policy approaches to intellectual property rights is argued in this paper, and several specific proposals are set out for further discussion.
The author concludes that the public policy problem, consequently, is to keep the two sub-systems in proper balance by public funding of “open science” research, and by checking excessive incursions of claims to private property rights over material that would otherwise remain in the public domain of scientific data and information.
The authors investigate the incidence of high technology acquisitions using a large international sample of acquisitions by public high technology firms.
This paper analyzes welfare implications of protecting intellectual property rights in the framework of TRIPS for developing countries through its impact on innovation, market structure and technology transfer.
This article attempts to provide an answer the question, "how much is my patent worth?" and is written to encourage start-up companies to look seriously at the value of their innovations and to consider ways that will make the most of their intellectual and capital investment.
In the spring of 2004, the DLA commissioned a survey focusing on 300 largest businesses across Europe. The survey indicates that most of the participating companies still do not have an IP management strategy in place, nor do they conduct valuation of their IP assets.
The goal of the report is to encourage better use of IPR by Nordic SMEs, in order to enhance their competitiveness. This project is part of the Nordic Innovation Centres Forum for Innovation Policies.
This article eschews the standard arguments premised on demonstrating the negative effects of unbridled strategic patenting. It argues instead that speculative biotech patenting, particularly of genetic probes, putative drug targets, and uncharacterized genetic sequences, is irrational.
The paper is concerned with the management of IP in inter-firm collaborative projects mediated through the use of advanced IT tools. Here, groups of firms, often competitors, and sometimes their customer organizations, collaborate in the design, development, manufacture and maintenance of complex products, exchanging large amounts of proprietary technical data through IT tools.
The authors study a situation of patent licensing where the technology transfer takes place from an innovative firm, which is relatively inefficient in terms of cost of production to its cost-efficient rival.